Public Health Emergency Preparedness
This resource was part of AHRQ's Public Health Emergency Preparedness program, which was discontinued on June 30, 2011, in a realignment of Federal efforts.
This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.
Please go to www.ahrq.gov for current information.
Table 6.8. Antibiotics for Treatment of Post-Radiation Neutropenia
Choice |
Antimicrobial |
Dosage and Route |
Comments and Spectrum of Activity |
First-choice antimicrobials (listed in order of potential efficacy) |
Cefepime |
150 mg/kg divided q 8 h, IV or IM |
Not available in oral form.
Activity against gram-positive organisms, except Enterococcus spp.
Activity against gram-negative organisms, including Pseudomonas aeruginosa and
certain Enterobacteriaceae that generally are resistant to most third-generation
cephalosporins. |
Ceftazidime |
100-300 mg/kg/day divided q 8 h |
May need to add amoxicillina or vancomycinb
Not available in oral form.
Activity against gram-negative organisms, including Pseudomonas aeruginosa and
certain Enterobacteriaceae that generally are resistant to most third-generation
cephalosporins. |
Ceftriaxone |
50-75 mg/kg/day, IV or IM, once a day |
Not available in oral form.
Activity against gram-positive organisms, except Enterococcus spp. |
Second-choice |
Gentamicin |
3-7.5 mg/kg/day divided q 8-24 h, IV or IM |
May need to add amoxicillina or vancomycinb
Not available in oral form. |
Amikacin |
15-22.5 mg/kg/day divided q 8 h, IV or IM |
May need to add amoxicillina or vancomycinb
Not available in oral form. |
Third-choice |
Ciprofloxacin |
20-30 mg/kg/day divided q 12 h, PO, IV, or IM |
May need to add amoxicillina or vancomycinb
Effective against gram-negative organisms and atypical bacteria.
Also effective against Pseudomonas species but poor coverage against gram-positive
organisms (including Staphylococcus aureus and nonhemolytic streptococci). |
Levofloxacin |
10 mg/kg/day, PO, IV, or IM |
May need to add amoxicillina or vancomycinb
Effective against gram-negative organisms and atypical bacteria.
More gram-positive coverage than ciprofloxacin. |
Gatifloxacin |
10 mg/kg/day, PO or IV |
Expanded spectrum against both gram-negative and gram-positive organisms.
Can be administered as single agent. |
a Dosage: 25-50 mg/kg/day divided q
8 h, PO
b Dosage: 40-60 mg/kg/day divided q 6-8 h, IV
Notes: PO = by mouth; IV = intravenous; IM = intramuscular.
Return to Document